Table of Content

1 Market Overview of Geriatric Medicines
1.1 Geriatric Medicines Market Overview
1.1.1 Geriatric Medicines Product Scope
1.1.2 Geriatric Medicines Market Status and Outlook
1.2 Global Geriatric Medicines Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Geriatric Medicines Market Size by Region (2018-2033)
1.4 Global Geriatric Medicines Historic Market Size by Region (2018-2023)
1.5 Global Geriatric Medicines Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Geriatric Medicines Market Size (2018-2033)
1.6.1 North America Geriatric Medicines Market Size (2018-2033)
1.6.2 Europe Geriatric Medicines Market Size (2018-2033)
1.6.3 Asia-Pacific Geriatric Medicines Market Size (2018-2033)
1.6.4 Latin America Geriatric Medicines Market Size (2018-2033)
1.6.5 Middle East & Africa Geriatric Medicines Market Size (2018-2033)
2 Geriatric Medicines Market by Type
2.1 Introduction
2.1.1 Analgesics
2.1.2 Antihypertensives
2.1.3 Statins
2.1.4 Antidiabetics
2.1.5 Proton Pump Inhibitor
2.1.6 Anticoagulant
2.1.7 Antipsychotics
2.1.8 Antidepressants
2.2 Global Geriatric Medicines Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Geriatric Medicines Historic Market Size by Type (2018-2023)
2.2.2 Global Geriatric Medicines Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Geriatric Medicines Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Geriatric Medicines Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Geriatric Medicines Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Geriatric Medicines Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Geriatric Medicines Revenue Breakdown by Type (2018-2033)
3 Geriatric Medicines Market Overview by Application
3.1 Introduction
3.1.1 Cardiovascular diseases
3.1.2 Arthritis
3.1.3 Neurological Disorders
3.1.4 Cancer
3.1.5 Osteoporosis
3.1.6 Respiratory
3.1.7 Other
3.2 Global Geriatric Medicines Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Geriatric Medicines Historic Market Size by Application (2018-2023)
3.2.2 Global Geriatric Medicines Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Geriatric Medicines Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Geriatric Medicines Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Geriatric Medicines Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Geriatric Medicines Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Geriatric Medicines Revenue Breakdown by Application (2018-2033)
4 Geriatric Medicines Competition Analysis by Players
4.1 Global Geriatric Medicines Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Geriatric Medicines as of 2022)
4.3 Date of Key Players Enter into Geriatric Medicines Market
4.4 Global Top Players Geriatric Medicines Headquarters and Area Served
4.5 Key Players Geriatric Medicines Product Solution and Service
4.6 Competitive Status
4.6.1 Geriatric Medicines Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eli Lilly and Company
5.1.1 Eli Lilly and Company Profile
5.1.2 Eli Lilly and Company Main Business
5.1.3 Eli Lilly and Company Geriatric Medicines Products, Services and Solutions
5.1.4 Eli Lilly and Company Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.1.5 Eli Lilly and Company Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Profile
5.2.2 AstraZeneca Main Business
5.2.3 AstraZeneca Geriatric Medicines Products, Services and Solutions
5.2.4 AstraZeneca Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.2.5 AstraZeneca Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Profile
5.3.2 Boehringer Ingelheim Main Business
5.3.3 Boehringer Ingelheim Geriatric Medicines Products, Services and Solutions
5.3.4 Boehringer Ingelheim Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Laboratories Recent Developments
5.4 Abbott Laboratories
5.4.1 Abbott Laboratories Profile
5.4.2 Abbott Laboratories Main Business
5.4.3 Abbott Laboratories Geriatric Medicines Products, Services and Solutions
5.4.4 Abbott Laboratories Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Laboratories Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Geriatric Medicines Products, Services and Solutions
5.5.4 Sanofi Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Bristol-Myers Squibb
5.6.1 Bristol-Myers Squibb Profile
5.6.2 Bristol-Myers Squibb Main Business
5.6.3 Bristol-Myers Squibb Geriatric Medicines Products, Services and Solutions
5.6.4 Bristol-Myers Squibb Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.6.5 Bristol-Myers Squibb Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Geriatric Medicines Products, Services and Solutions
5.7.4 Merck Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Geriatric Medicines Products, Services and Solutions
5.8.4 Novartis Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis Recent Developments
5.9 Pfizer
5.9.1 Pfizer Profile
5.9.2 Pfizer Main Business
5.9.3 Pfizer Geriatric Medicines Products, Services and Solutions
5.9.4 Pfizer Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.9.5 Pfizer Recent Developments
5.10 GSK
5.10.1 GSK Profile
5.10.2 GSK Main Business
5.10.3 GSK Geriatric Medicines Products, Services and Solutions
5.10.4 GSK Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.10.5 GSK Recent Developments
6 North America
6.1 North America Geriatric Medicines Market Size by Country (2018-2033)
6.2 the United States
6.3 Canada
7 Europe
7.1 Europe Geriatric Medicines Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Geriatric Medicines Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Geriatric Medicines Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Geriatric Medicines Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Geriatric Medicines Market Dynamics
11.1 Geriatric Medicines Industry Trends
11.2 Geriatric Medicines Market Drivers
11.3 Geriatric Medicines Market Challenges
11.4 Geriatric Medicines Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Geriatric Medicines Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Geriatric Medicines Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Geriatric Medicines Market Size Share by Region (2018-2023)
Table 4. Global Geriatric Medicines Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Geriatric Medicines Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Geriatric Medicines Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Geriatric Medicines Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Geriatric Medicines Revenue Market Share by Type (2018-2023)
Table 9. Global Geriatric Medicines Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Geriatric Medicines Revenue Market Share by Type (2024-2033)
Table 11. North America Geriatric Medicines Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Geriatric Medicines Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Geriatric Medicines Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Geriatric Medicines Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Geriatric Medicines Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Geriatric Medicines Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Geriatric Medicines Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Geriatric Medicines Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Geriatric Medicines Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Geriatric Medicines Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Geriatric Medicines Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Geriatric Medicines Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Geriatric Medicines Revenue Market Share by Application (2018-2023)
Table 24. Global Geriatric Medicines Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Geriatric Medicines Revenue Market Share by Application (2024-2033)
Table 26. North America Geriatric Medicines Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Geriatric Medicines Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Geriatric Medicines Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Geriatric Medicines Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Geriatric Medicines Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Geriatric Medicines Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Geriatric Medicines Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Geriatric Medicines Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Geriatric Medicines Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Geriatric Medicines Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Geriatric Medicines Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Geriatric Medicines Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Geriatric Medicines as of 2022)
Table 39. Date of Key Players Enter into Geriatric Medicines Market
Table 40. Global Geriatric Medicines Key Players Headquarters and Area Served
Table 41. Geriatric Medicines Product Solution and Service
Table 42. Global Geriatric Medicines Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Eli Lilly and Company Basic Information List
Table 45. Eli Lilly and Company Description and Business Overview
Table 46. Eli Lilly and Company Geriatric Medicines Products, Services and Solutions
Table 47. Revenue (US$ Million) in Geriatric Medicines Business of Eli Lilly and Company (2018-2023)
Table 48. Eli Lilly and Company Recent Developments
Table 49. AstraZeneca Basic Information List
Table 50. AstraZeneca Description and Business Overview
Table 51. AstraZeneca Geriatric Medicines Products, Services and Solutions
Table 52. Revenue (US$ Million) in Geriatric Medicines Business of AstraZeneca (2018-2023)
Table 53. AstraZeneca Recent Developments
Table 54. Boehringer Ingelheim Basic Information List
Table 55. Boehringer Ingelheim Description and Business Overview
Table 56. Boehringer Ingelheim Geriatric Medicines Products, Services and Solutions
Table 57. Revenue (US$ Million) in Geriatric Medicines Business of Boehringer Ingelheim (2018-2023)
Table 58. Boehringer Ingelheim Recent Developments
Table 59. Abbott Laboratories Basic Information List
Table 60. Abbott Laboratories Description and Business Overview
Table 61. Abbott Laboratories Geriatric Medicines Products, Services and Solutions
Table 62. Revenue (US$ Million) in Geriatric Medicines Business of Abbott Laboratories (2018-2023)
Table 63. Abbott Laboratories Recent Developments
Table 64. Sanofi Basic Information List
Table 65. Sanofi Description and Business Overview
Table 66. Sanofi Geriatric Medicines Products, Services and Solutions
Table 67. Revenue (US$ Million) in Geriatric Medicines Business of Sanofi (2018-2023)
Table 68. Sanofi Recent Developments
Table 69. Bristol-Myers Squibb Basic Information List
Table 70. Bristol-Myers Squibb Description and Business Overview
Table 71. Bristol-Myers Squibb Geriatric Medicines Products, Services and Solutions
Table 72. Revenue (US$ Million) in Geriatric Medicines Business of Bristol-Myers Squibb (2018-2023)
Table 73. Bristol-Myers Squibb Recent Developments
Table 74. Merck Basic Information List
Table 75. Merck Description and Business Overview
Table 76. Merck Geriatric Medicines Products, Services and Solutions
Table 77. Revenue (US$ Million) in Geriatric Medicines Business of Merck (2018-2023)
Table 78. Merck Recent Developments
Table 79. Novartis Basic Information List
Table 80. Novartis Description and Business Overview
Table 81. Novartis Geriatric Medicines Products, Services and Solutions
Table 82. Revenue (US$ Million) in Geriatric Medicines Business of Novartis (2018-2023)
Table 83. Novartis Recent Developments
Table 84. Pfizer Basic Information List
Table 85. Pfizer Description and Business Overview
Table 86. Pfizer Geriatric Medicines Products, Services and Solutions
Table 87. Revenue (US$ Million) in Geriatric Medicines Business of Pfizer (2018-2023)
Table 88. Pfizer Recent Developments
Table 89. GSK Basic Information List
Table 90. GSK Description and Business Overview
Table 91. GSK Geriatric Medicines Products, Services and Solutions
Table 92. Revenue (US$ Million) in Geriatric Medicines Business of GSK (2018-2023)
Table 93. GSK Recent Developments
Table 94. North America Geriatric Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 95. North America Geriatric Medicines Market Size by Country (2024-2033) & (US$ Million)
Table 96. Europe Geriatric Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 97. Europe Geriatric Medicines Market Size by Country (2024-2033) & (US$ Million)
Table 98. Asia-Pacific Geriatric Medicines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 99. Asia-Pacific Geriatric Medicines Market Size by Region (2018-2023) & (US$ Million)
Table 100. Asia-Pacific Geriatric Medicines Market Size by Region (2024-2033) & (US$ Million)
Table 101. Asia-Pacific Geriatric Medicines Market Share by Region (2018-2023)
Table 102. Asia-Pacific Geriatric Medicines Market Share by Region (2024-2033)
Table 103. Latin America Geriatric Medicines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 104. Latin America Geriatric Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 105. Latin America Geriatric Medicines Market Size by Country (2024-2033) & (US$ Million)
Table 106. Middle East & Africa Geriatric Medicines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 107. Middle East & Africa Geriatric Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 108. Middle East & Africa Geriatric Medicines Market Size by Country (2024-2033) & (US$ Million)
Table 109. Geriatric Medicines Market Trends
Table 110. Geriatric Medicines Market Drivers
Table 111. Geriatric Medicines Market Challenges
Table 112. Geriatric Medicines Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geriatric Medicines Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Geriatric Medicines Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Geriatric Medicines Market Share by Regions: 2022 VS 2033
Figure 4. Global Geriatric Medicines Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Geriatric Medicines Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Geriatric Medicines Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Geriatric Medicines Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Geriatric Medicines Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Geriatric Medicines Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Analgesics
Figure 11. Global Analgesics Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Antihypertensives
Figure 13. Global Antihypertensives Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Statins
Figure 15. Global Statins Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Antidiabetics
Figure 17. Global Antidiabetics Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Product Picture of Proton Pump Inhibitor
Figure 19. Global Proton Pump Inhibitor Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 20. Product Picture of Anticoagulant
Figure 21. Global Anticoagulant Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Product Picture of Antipsychotics
Figure 23. Global Antipsychotics Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Product Picture of Antidepressants
Figure 25. Global Antidepressants Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Global Geriatric Medicines Market Size Share by Type: 2022 & 2033
Figure 27. North America Geriatric Medicines Revenue Market Share by Type (2018-2033)
Figure 28. Europe Geriatric Medicines Revenue Market Share by Type (2018-2033)
Figure 29. Asia-Pacific Geriatric Medicines Revenue Market Share by Type (2018-2033)
Figure 30. Latin America Geriatric Medicines Revenue Market Share by Type (2018-2033)
Figure 31. Middle East and Africa Geriatric Medicines Revenue Market Share by Type (2018-2033)
Figure 32. Cardiovascular diseases Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 33. Arthritis Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 34. Neurological Disorders Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 35. Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 36. Osteoporosis Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 37. Respiratory Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 38. Other Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 39. Global Geriatric Medicines Market Size Share by Application: 2022 & 2033
Figure 40. North America Geriatric Medicines Revenue Market Share by Application (2018-2033)
Figure 41. Europe Geriatric Medicines Revenue Market Share by Application (2018-2033)
Figure 42. Asia-Pacific Geriatric Medicines Revenue Market Share by Application (2018-2033)
Figure 43. Latin America Geriatric Medicines Revenue Market Share by Application (2018-2033)
Figure 44. Middle East and Africa Geriatric Medicines Revenue Market Share by Application (2018-2033)
Figure 45. Geriatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 46. Global Top 5 and Top 10 Players Geriatric Medicines Market Share in 2022
Figure 47. North America Geriatric Medicines Market Share by Country (2018-2033)
Figure 48. the United States Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 49. Canada Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 50. Germany Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 51. France Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 52. U.K. Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 53. Italy Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 54. Russia Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 55. Nordic Countries Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 56. Asia-Pacific Geriatric Medicines Market Share by Region (2018-2033)
Figure 57. China Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 58. Japan Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 59. South Korea Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 60. Southeast Asia Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 61. India Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 62. Australia Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 63. Latin America Geriatric Medicines Market Share by Country (2018-2033)
Figure 64. Mexico Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 65. Brazil Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 66. Middle East & Africa Geriatric Medicines Market Share by Country (2018-2033)
Figure 67. Turkey Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 68. Saudi Arabia Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 69. UAE Geriatric Medicines Market Size (2018-2033) & (US$ Million)
Figure 70. Bottom-up and Top-down Approaches for This Report